| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.44 | 2e-18 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.31 | 9e-18 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.29 | 9e-15 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.27 | 7e-13 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-12 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-12 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-11 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.23 | 7e-11 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-10 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-09 |